LITE Surges to $672 on Marvell Rebound as Deal Spread Holds at 16.4% — Full Deal Value Targets $782.87

LITE Surges to $672 on Marvell Rebound as Deal Spread Holds at 16.4% — Full Deal Value Targets $782.87

Lumentum guides Q2 revenue to $1.575B–$1.625B with margins above 45% | That's TradingNEWS

Itai Smidt 11/11/2026 12:24:12 PM

Key Points

  • LITE jumped 14.85% to $672.54 as Marvell rose 12.68% to $173.97, lifting the value of 4.5 Marvell shares to $782.87.
  • Lumentum’s Q1 fiscal 2027 revenue rose 136.5% to $1.2626B, beating the top of its $1.225B–$1.275B guidance.
  • LITE trades 16.4% below the $782.87 value of 4.5 Marvell shares, the upside target if the deal spread closes.

Lumentum Holdings (NASDAQ:LITE) traded at $672.54 at 12:24 p.m. ET on Wednesday, up $86.97 or 14.85% from Tuesday’s $585.57 close. The stock rose 9.1% in the premarket as AI chip and optical stocks rallied on CoreWeave’s earnings. Marvell Technology (NASDAQ:MRVL), which agreed on November 2 to buy Lumentum for 4.5 Marvell shares per Lumentum share, was up 12.68% to $173.97 at 12:31 p.m. Because the deal pays in Marvell stock, Lumentum’s price now moves largely with Marvell’s.

The rally comes after a steep drop. Lumentum’s record close was $1,133.40 on October 6, 2026. At $672.54 it is still 40.7% below that level. The stock lost 36.9% in the month to November 2. On the day the deal was announced it fell 18.6% to $684.40, its biggest one-day drop in a year. By November 6 it had fallen nearly 40% in a week as worries about data center construction after the U.S. midterms combined with doubts about the deal. Tuesday’s $585.57 close was 14.4% below the deal-day close.

The thesis for LITE now has two parts. Lumentum’s own business is growing fast. Revenue rose 136.5% to $1.26 billion in the quarter ended September 26. Next quarter’s guidance calls for $1.575 billion to $1.625 billion, with operating margins above 45%. Separately, the stock trades as a discounted claim on 4.5 Marvell shares. At Marvell’s $173.97, those shares are worth $782.87, 16.4% above Lumentum’s price. Today’s rally reflects both factors: a stronger Marvell and a market more willing to pay for AI optical components.

The deal spread is the most important number for the stock. At Marvell’s prior close of $154.39, 4.5 Marvell shares were worth $694.76, against Lumentum’s $585.57 close. That was a spread of $109.19, or 18.6%. Today the spread is $110.33, or 16.4% of Lumentum’s price. The dollar spread has barely changed, but the percentage has narrowed because both stocks rose. On November 2, the spread was $86.95, or 12.7%. It has widened since the deal was announced, showing that the market doubts the deal will close on its terms.

The rally is part of a broad chip rebound. Marvell rose as much as 12.7%, Micron rose 7%, Intel 6.6%, Arm 6.2% and Broadcom 5.8% during the session. Sandisk, Coherent and Credo rose 7% to 9% before the open. FormFactor jumped 10.87% on a new Buy rating. CoreWeave rose 21.6% after its third-quarter revenue beat. The Nasdaq Composite rose 1.77% and the S&P 500 1.09%. Lumentum’s 14.85% gain is among the strongest moves in the AI hardware rally.

Q1 Fiscal 2027: Revenue of $1.26 Billion, Up 136.5%, Beats the Top of Guidance

Lumentum reported fiscal first-quarter 2027 results on November 2 for the quarter ended September 26. Net revenue was $1.2626 billion, up 136.5% from $533.8 million a year earlier and up 25.5% from $1.0063 billion in the prior quarter. It beat the company’s own forecast of $1.225 billion to $1.275 billion. Lumentum reached its target financial model more than a quarter ahead of schedule.

Profit grew even faster. GAAP net income was $360.3 million, or $3.54 a diluted share, against $4.2 million, or $0.05, a year earlier. Non-GAAP net income was $461.1 million, or $4.57 a share, above the $4.05 to $4.35 guidance range. Non-GAAP earnings rose from $1.10 a share a year earlier and $3.23 in the prior quarter. Per-share profit has quadrupled in one year.

Margins expanded sharply. GAAP gross margin was 51.0% and non-GAAP gross margin was 53.2%. GAAP operating margin was 28.5%, up 2,720 basis points from 1.3% a year earlier. Non-GAAP operating margin was 42.3%, above the 39.5% to 40.5% guidance and up 2,360 basis points from a year earlier. Management credited a richer product mix, higher factory utilization and selective pricing.

CEO Michael Hurlston said growth came from all of the company’s businesses, with pump lasers and optical circuit switches as the main drivers. Cloud modules, Lumentum’s transceivers for data centers, showed better gross margins. The company also secured its second major contract for lasers used in near-packaged and co-packaged optics, backed by more than $5 billion of purchase commitments. That is larger than Lumentum’s entire fiscal 2026 revenue of $3.014 billion.

The quarter shows how far Lumentum has come. Fiscal 2026 revenue rose 83.2% to $3.014 billion, and the full-year non-GAAP operating margin reached 29.8%, up from 9.7% in fiscal 2025. Two years ago, the company’s whole quarterly revenue was smaller than the $350 million it now expects to add in a single quarter. The stock fell 18.6% on results day only because of the deal terms, not because of the results.

Q2 Guidance: $1.575–$1.625 Billion in Revenue and Operating Margins Above 45%

Lumentum guided second-quarter fiscal 2027 revenue to $1.575 billion to $1.625 billion. At the $1.6 billion midpoint, that is 26.7% above the first quarter’s $1.2626 billion, an increase of $337 million in one quarter. Management said it expects to add about $350 million in sequential growth, more than the company’s entire quarterly revenue two years ago.

Margins are guided even higher. Non-GAAP operating margin is guided at 45.0% to 46.0%, up from 42.3% in the first quarter. Management said it expects the second-quarter operating margin to exceed 45%. Non-GAAP earnings are guided at $5.90 to $6.20 a share. At the $6.05 midpoint, that is 32.4% above the first quarter’s $4.57.

The guidance implies a very fast growth rate. A $1.6 billion quarter annualizes to $6.4 billion of revenue, more than double fiscal 2026’s $3.014 billion. Midpoint earnings of $6.05 a quarter annualize to $24.20 a share. At $672.54, that puts the stock at 27.8 times annualized earnings. That multiple is modest for a company growing revenue more than 100% a year.

The drivers are clear. Optical circuit switches had their first quarter above $100 million in revenue in the first quarter, and management now sees them becoming a multi-billion-dollar annual business. The shift from 800G to 1.6T transceivers is speeding up through calendar 2027. Demand for ultra-high-power lasers for co-packaged optics is rising, with the lead customer planning high-volume shipments in the second half of 2027 for 2028 deployments.

The guidance is credible because Lumentum has beaten its own forecasts repeatedly. The first quarter beat the top of the revenue range and the top of the margin range. The fourth quarter of fiscal 2026 also beat estimates. Laser supply is tight across the industry, which gives Lumentum pricing power. The main risk to the guidance is execution: expanding indium phosphide (InP) laser capacity, including at a new fab in Greensboro, North Carolina, fast enough to meet demand.

Components and Systems: Systems Revenue Up 228.8% to $508.4 Million

Lumentum reports two segments. Components, which includes laser chips and subassemblies, generated $754.2 million in the first quarter, 59.7% of revenue. That was up 16.1% from the prior quarter and up 98.9% from $379.2 million a year earlier. Pump lasers, used to amplify optical signals in data center networks, were the main driver.

Systems, which includes cloud transceivers, optical circuit switches and industrial lasers, grew faster. It generated $508.4 million, 40.3% of revenue. That was up 42.4% from the prior quarter and up 228.8% from $154.6 million a year earlier. Systems’ share of revenue rose to 40.3% from 29% a year earlier, as optical circuit switches added a second major product alongside transceivers.

Optical circuit switches are Lumentum’s newest growth story. These devices route data with light instead of converting it to electrical signals, cutting power use and delay in AI clusters. Shipments doubled from the third to the fourth quarter of fiscal 2026. The first quarter of fiscal 2027 was the first with more than $100 million in OCS revenue. Hurlston said demand visibility has expanded significantly in recent months.

Cloud transceivers are the core of the systems business. Lumentum shipped a record number of 800G transceivers in the fourth quarter of fiscal 2026 and began production shipments of 1.6T modules. Most shipments are still 800G, but 1.6T adoption is accelerating. Margins on cloud modules have historically been lower than on components, so the improvement Hurlston cited matters for the company’s overall profitability.

The $5 billion contract is the largest single item in the outlook. It is Lumentum’s second major win in near-packaged and co-packaged optics, designs that place optical connections right next to the processor chip. The first major win came the previous year. The $5 billion exceeds Lumentum’s fiscal 2026 revenue, though the company did not give a delivery schedule. Once shipments start, it would lift components revenue substantially.

Cash Falls $758.8 Million to $2.0 Billion: The Cost of Building Capacity

Lumentum ended the first quarter with $2.0 billion in cash, cash equivalents and short-term investments, down $758.8 million from the end of fiscal 2026. That decline came despite $461.1 million of non-GAAP net income in the quarter, which points to heavy spending on capacity. The company ended fiscal 2026 with $2.7 billion, up $1.9 billion from the prior year.

Most of the cash went into capacity. Lumentum is building laser manufacturing capacity, including a new InP fab in Greensboro, to meet demand for pump lasers, transceivers and co-packaged optics lasers. Laser supply is the tightest part of the AI optical supply chain. Lumentum has said it is expanding capacity to prepare for near- and co-packaged optics deployments in 2027 and 2028.

Lumentum’s balance sheet carries one-time scars. In the fourth quarter of fiscal 2026, the company reported a GAAP net loss of $7.2 billion, or $84.65 a share, because of an unusual accounting charge. On a trailing 12-month basis, the company still shows a GAAP loss of $6.6 billion because of that charge. Investors focus on non-GAAP earnings because the charge does not reflect operating performance.

Nvidia is a strategic investor. In March 2026 Nvidia invested $2 billion in Lumentum along with a multiyear laser supply agreement, and later invested $2 billion in Marvell. Those investments secure Nvidia’s access to lasers and optical connections for its AI systems. They also tie Lumentum’s fortunes to Nvidia’s, whose board is investigating reports that its CEO was the target of a foreign intelligence effort.

For the forecast, the cash drain matters less once the deal closes. If Marvell completes the purchase, capacity spending will be funded by a combined company with Marvell’s larger balance sheet. Until the deal closes in the first half of 2028, Lumentum must fund its own buildout. A cash balance of $2.0 billion, generating more than $400 million of quarterly non-GAAP earnings, covers that comfortably. The spending pays off if the $5 billion contract and OCS demand arrive on schedule.

The Marvell Deal: 4.5 Shares, $115 Billion and a Closing Target in the First Half of 2028

Marvell agreed on November 2 to buy Lumentum in an all-stock deal valued at $115 billion, including debt. Lumentum holders will receive 4.5 Marvell shares for each Lumentum share. At the October 28 prices before the talks became public, that was worth $1,132 per share, a 23.9% premium. Marvell holders will own 67% of the combined company and Lumentum holders 33%. The deal is expected to close in the first half of 2028.

The terms leave Lumentum holders exposed to Marvell’s stock price. The ratio is fixed, so every $1 drop in Marvell reduces the deal value per Lumentum share by $4.50. Marvell fell 13.2% on October 29 when reports of the talks surfaced, 10.0% on October 30 and 12.7% on November 2. By November 2 it had lost 37.0% in a month and closed at $171.41, 46% below its 52-week closing high of $316.43 on June 4. This week it reached a low of $132.

The deal has a long timeline and strong protections. The initial outside date is November 1, 2027, extendable to August 1, 2028. Marvell must pay a $3.2 billion regulatory termination fee if antitrust or regulatory approval fails. Lumentum shareholders must approve the deal, and Marvell shareholders must approve issuing the new shares and raising its authorized share count. Three Lumentum directors, including Hurlston, will join Marvell’s board, and Marvell CEO Matt Murphy will run the combined company.

The strategy is built on optical connectivity. Marvell designs custom chips, networking switches and digital signal processors. Lumentum makes lasers, transceivers and optical circuit switches, with its own InP manufacturing. The companies call the combination “extreme co-design.” They claim a combined addressable market of $550 billion and expect more than $1 billion a year in cost savings. Marvell’s CEO called the shift from copper to optical connections in AI data centers a generational opportunity.

Investors have been skeptical. Both stocks fell on announcement day, together losing nearly $28 billion in market value. Critics question the price, Marvell’s move into manufacturing after years as a chip designer, and the possibility of conflicts with Marvell’s customers who compete with Lumentum. Lumentum’s CEO argued that Lumentum chose all stock because the combined company has significant upside. Investors still need to see that view reflected in Marvell’s share price.

Deal Spread at 16.4%: Lumentum Trades Below Its Implied Value

The deal spread is the key number for LITE. At Marvell’s $173.97, the 4.5 shares Lumentum holders will receive are worth $782.87. Lumentum trades at $672.54, so the spread is $110.33, or 16.4% above Lumentum’s price. Lumentum trades at 85.9% of its deal value. An investor buying Lumentum today and holding until the deal closes would earn 16.4% plus any gain in Marvell’s stock, assuming the deal closes on its terms.

The spread has widened since the announcement. On November 2, Marvell closed at $171.41, so the deal was worth $771.35 per Lumentum share against Lumentum’s $684.40 close. The spread was $86.95, or 12.7%. On Tuesday the spread was $109.19, or 18.6%. Today’s 16.4% is better than Tuesday but still wider than at the announcement. The market is pricing more risk that the deal could fail or be renegotiated.

A wide spread reflects several risks. The deal will not close until the first half of 2028, more than a year away. That time value alone justifies part of the spread, especially with interest rates rising: futures price a December Fed hike at 100%, and Treasuries pay close to 5%. Regulators could block or delay the deal. Shareholders at either company could vote against it. Marvell’s stock could keep falling and reduce the deal’s value.

The spread is also a potential gain. If the deal closes, the spread disappears, and Lumentum holders receive the full value of 4.5 Marvell shares. If Marvell’s stock rises in the meantime, Lumentum holders gain on two fronts: the spread narrowing and Marvell rising. A 16.4% spread over 18 months is an annualized return of about 10.6% before any change in Marvell’s price, well above the 5% available from Treasuries.

If the deal fails, Lumentum would trade on its own fundamentals again. With revenue growth above 100%, guidance for a $1.6 billion quarter and a $5 billion contract, Lumentum might be valued above its current price on its own. Its record close was $1,133.40, which was set before the deal and before the AI selloff. Marvell’s $3.2 billion termination fee would provide some support if regulators block the deal. The spread caps upside but also limits downside, as long as Marvell’s stock holds.

Marvell Stock: The Main Driver of Lumentum’s Price

Marvell’s stock now drives most of Lumentum’s daily moves. Marvell was at $173.97 at 12:31 p.m., up $19.58 or 12.68% from Tuesday’s $154.39 close. It traded at $167.50 in the premarket, 25% above its low of $132 this week. Its record high was $329 in June. At $173.97, Marvell is 47.1% below that high. The stock has a market value of $152.74 billion and 877.99 million shares outstanding.

Marvell’s fundamentals are strong. Trailing 12-month revenue is $9.45 billion, up 30.6%, with net income of $2.64 billion. Earnings per share over the past year are $2.98, giving a price-to-earnings ratio of 58.45, and the forward P/E is 30.85. Management guided data center revenue for the fiscal third quarter to grow about 75% from a year earlier. Marvell reports later in November, a key catalyst for both stocks.

Marvell’s drop came from two directions. Its stock fell 37% in the month to November 2 as reports of the Lumentum talks spread and investors questioned the price. It also fell with the broader AI selloff, in which the Philadelphia Semiconductor Index lost 12.3% on November 5. Marvell has also faced worries about the timing of revenue from a Google AI deal, which pushed the stock down 8% after its August results.

The average 12-month price target for Marvell across 43 analysts is $310.94, 78.7% above the current price. Recent revisions have been mostly lower: one firm cut its target to $250 from $275 after earlier cutting it from $365. Even at reduced targets, analysts see substantial upside. For Lumentum, a Marvell target of $250 would imply a deal value of $1,125, 67.3% above Lumentum’s current price.

For the forecast, Lumentum’s next move depends mostly on Marvell. Every $10 Marvell gains adds $45 to the deal value per Lumentum share. A Marvell recovery to $200 would put the deal value at $900, 33.8% above Lumentum’s current price. A drop back to the $132 low would put it at $594, below Lumentum’s price, and the stock would likely fall with it. Marvell’s earnings later this month are therefore the most important event for LITE.

Valuation: 27.8 Times Annualized Earnings and 10.6 Times Run-Rate Sales

At $672.54, Lumentum’s equity is worth $67.9 billion, based on 100.9 million diluted shares. That share count comes from the first quarter’s non-GAAP net income of $461.1 million divided by $4.57 a share. The deal’s $115 billion enterprise value was set at Marvell’s October 28 price. At today’s Marvell price, the implied equity value of the deal for Lumentum holders is $79.0 billion.

On an earnings basis, LITE trades at 27.8 times its annualized second-quarter guidance. The $6.05 midpoint annualizes to $24.20 a share. The first quarter’s $4.57 annualizes to $18.28, a multiple of 36.8. With quarterly earnings growing 32% in one quarter, the forward multiple is falling fast. If the company keeps adding $350 million in revenue a quarter, earnings could pass $28 a share on an annualized basis within two quarters.

On a revenue basis, LITE trades at 10.6 times the $6.4 billion annualized run rate from second-quarter guidance. Against fiscal 2026 revenue of $3.014 billion, the multiple is 22.5. The gap shows how fast the business is growing. Compared with other fast-growing AI hardware companies, Lumentum’s multiples are reasonable, especially with operating margins above 45%.

Analyst targets have been cut sharply since the deal. One firm lowered its target to $686 from $960 and kept a Neutral rating after the September quarter met expectations. Another cut its target to $635 from $900, then raised it to $700 to reflect Marvell’s latest share price. Those revisions show analysts now value Lumentum mostly through the deal ratio and Marvell’s price.

For the forecast, valuation supports buying LITE below its deal value. At 27.8 times annualized earnings with revenue growth above 100%, the stock is reasonably priced on its own. As a deal, it trades 16.4% below the value of 4.5 Marvell shares. Both measures point to upside, conditional on Marvell’s stock holding and the deal remaining on track.

Competition and Supply: Coherent, Ciena, Credo and the Race for Lasers

Lumentum competes in a tight market for AI optics. Coherent (NYSE:COHR) is its closest competitor in lasers and transceivers. It rose 2% on the deal day, as investors saw the merger as potentially pushing customers who don’t want to rely on a Marvell-owned supplier toward Coherent. Coherent, Sandisk and Credo (NASDAQ:CRDO) rose 7% to 9% in today’s premarket. Ciena (NYSE:CIEN), a supplier of optical networking systems, has also rallied with the group this year.

Laser supply is the bottleneck. Lumentum’s InP fab is one of the largest sources of the lasers used in AI data center optics. Marvell’s management said tight laser supply was not the reason for the deal but a byproduct of its view that demand for optical connections inside AI systems has arrived. Telecom and data center buyers are competing for the same limited laser supply. Owning a laser fab gives Marvell secure supply, and could limit what competitors can buy.

That creates a risk of conflict. Marvell sells chips to companies that also buy Lumentum lasers and transceivers, and some of those customers compete with Marvell. After the merger they may be reluctant to depend on a supplier owned by a competitor. That could push some business toward Coherent or other laser suppliers. Lumentum’s $5 billion contract shows that customers are committing now, but future contracts could be affected.

Nvidia is both a customer and an investor in the group. It has invested in both Lumentum and Marvell, secured a multiyear laser supply agreement with Lumentum, and relies on optical connections for its next-generation AI systems. Nvidia’s earnings on November 17 will update investors on demand for its data center chips, which drives demand for Lumentum’s lasers and transceivers.

For the forecast, the competitive picture is favorable while supply stays tight. As long as AI demand exceeds laser capacity, Lumentum can sell everything it makes at strong prices, regardless of the merger. Risk would rise if supply catches up with demand in 2028, when the deal closes and competitors’ capacity expansions come online. That timeline means Lumentum’s growth through fiscal 2027 looks secure.

Technical Map: $585.57 Support, $684.40 Gap Level, $782.87 Upside Target

LITE’s chart shows a sharp decline with a strong bounce today. The stock fell from its $1,133.40 record close on October 6 to Tuesday’s $585.57 close, a 48.3% drop. Today’s 14.85% rally to $672.54 recovered a portion of that. The stock trades below its key moving averages, and the downtrend from October remains intact until it recovers higher levels.

Support comes in layers. The first is Tuesday’s close of $585.57, the bottom of the recent decline. A close below that would open $550 and then $500. A stronger floor sits where the deal value would fall if Marvell returned to its $132 low: 4.5 times $132 is $594. Lumentum dropping well below $594 would mean the market is pricing a significant chance the deal fails.

Resistance comes in layers too. The first is $684.40, the deal-day close on November 2, 1.8% above the current price. A close above that would recover the deal-day level and signal that investors are giving the deal more credit. The second is $771.35, the deal value at Marvell’s November 2 close. The third is $782.87, the deal value at Marvell’s current $173.97.

The upside target is $782.87, 16.4% above the current price, where Lumentum would trade at the full value of 4.5 Marvell shares at today’s price. Reaching it requires the deal spread to close, which is unlikely until the deal nears completion in 2028. A more realistic near-term target is the spread narrowing to the 12.7% level of announcement day. At today’s Marvell price, that would put LITE at $694.71.

Volatility is extreme. Lumentum fell 18.6% in one day on November 2 and rose 14.85% today. Marvell moves 10% to 13% on single days, and Lumentum moves with it. Position sizes need to reflect daily swings of 10% or more. Traders should watch Marvell’s price and the spread together, since Lumentum’s moves follow both.

Lumentum Stock Forecast Verdict: Bullish While Above $585.57, $782.87 Deal-Value Target

The bull case is strong. Lumentum’s first-quarter revenue rose 136.5% to $1.2626 billion, beating guidance. The non-GAAP operating margin reached 42.3%, and second-quarter guidance calls for $1.6 billion in revenue and margins above 45%. A second $5 billion contract for co-packaged optics lasers exceeds the company’s entire fiscal 2026 revenue. Optical circuit switches are on track to become a multi-billion-dollar business. The stock trades at 27.8 times annualized earnings and 16.4% below the value of 4.5 Marvell shares.

The bear case centers on the deal. Lumentum’s price now depends on Marvell’s, and Marvell has fallen from $329 to as low as $132. The deal will not close until the first half of 2028, and regulators or shareholders could block it. The spread has widened to 16.4% from 12.7% on announcement day, showing growing doubts. Rising interest rates make waiting 18 months for a deal payout less attractive. Conflicts with Marvell’s customers could slow future contract wins.

The near-term range is $585.57 to $684.40, with Marvell’s price as the main driver. A close above $684.40, the deal-day level, opens $771.35 and then $782.87. A close below $585.57 would expose the $550 to $594 zone, where the deal value would sit if Marvell retested its low.

The catalysts are close together. Nebius reports Thursday, and its results will move the AI infrastructure group. Nvidia reports November 17. Lumentum holds its annual shareholder meeting on November 18. Marvell reports fiscal third-quarter results later in November, which is the most important event for LITE because it sets Marvell’s price and the deal value. Shareholder votes on the merger and regulatory filings will follow over the coming months.

The forecast is bullish while LITE holds above $585.57. The upside target is $782.87, 16.4% above $672.54, where Lumentum would trade at the full value of 4.5 Marvell shares at today’s price. Reaching it requires Marvell to hold above $170 and the market to gain confidence that the deal will close. Over the longer term, LITE’s value depends on Marvell’s stock: a recovery to $200 would put the deal value at $900, while a drop to $132 would put it at $594. Lumentum’s own business growth gives a floor if the deal fails.

That's TradingNEWS